HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Neurology 2025

PNeuroplasticity-driven cognitive intervention for opioid addiction: A randomized controlled trial

Speaker at Neurology and Neurological Disorders 2025 - Jinyan Guo
The Third Affiliated Hospital of Sun Yat-sen University, China
Title : PNeuroplasticity-driven cognitive intervention for opioid addiction: A randomized controlled trial

Abstract:

Purpose: Opioid use disorder (OUD) is distinguished by its high relapse rates and intricate neuropsychological mechanisms, with conventional therapies exhibiting limited efficacy. The present study aims to evaluate the effectiveness of a neuroplasticity-targeted cognitive intervention (NCI) in enhancing executive functioning, mitigating impulsivity, and preventing relapse, thereby contributing to the advancement of neuroscience-informed strategies in addiction psychiatry.

Method: A 12-week randomized, double-blind controlled trial was conducted at the Third Affiliated Hospital of Sun Yat-sen University. The study population comprised 120 participants (N=120) who had been diagnosed with OUD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and had undergone detoxification. These participants were randomly assigned to either the NCI group (n=60) or the cognitive behavioral therapy (CBT) group (n=60).The NCI protocol included:

  • Adaptive cognitive training: Dynamic N-back and modified Iowa gambling tasks to strengthen prefrontal-striatal circuitry;
  • Real-time fMRI neurofeedback: Targeting dlPFC-NAc functional connectivity to modulate reward-related neural activity;
  • Virtual reality-based episodic future thinking: Simulating adverse consequences to improve decision-making.
  • Outcomes included neuroimaging (resting/task fMRI), impulsivity (BIS-11), relapse rates, and social function at baseline, post-intervention, and 6-month follow-up.

Results: 

  • Neuroplasticity: NCI significantly enhanced dlPFC-NAc connectivity (Δ=0.32, p<0.001), correlating with reduced impulsivity (BIS-11↓38.7%, p<0.01).
  • Cognitive Gains: NCI outperformed CBT in delayed discounting (2.1 vs. 0.8-fold improvement, p=0.007) and working memory accuracy (+19.3%, p<0.01).
  • Relapse Reduction: NCI group exhibited lower 6-month relapse rates (31.7% vs. 56.4%; HR=0.52, 95%CI 0.32–0.85).
  • Dose-Response: Neurofeedback duration inversely predicted NAc activation (r=-0.71, p=0.003), confirming intervention specificity.

Conclusion: This trial demonstrates that NCI induces sustained neurobehavioral improvements in OUD by augmenting prefrontal regulation and attenuating hyperactive reward processing.

Keywords: Opioid Addiction; Neuroplasticity; Cognitive Intervention; Real-Time Fmri Neural Feedback; Executive Function

Biography:

Ph.D. in Cognitive Neuroscience, Sun Yat-sen University, Research Focus: Neuroplasticity-driven interventions for addiction psychiatry, integrating fMRI neurofeedback and cognitive remediation to address opioid use disorder (OUD). Recipient of the National Natural Science Foundation of China Young Scientist Award (2023) for pioneering work in neurocognitive addiction therapies.

Watsapp